MD, PhD, hematologist, consultant in internal medicine. She deals with the diagnosis and treatment of patients with blood diseases, especially lymphoproliferative disorders and cardiotoxicity issues in oncological treatment. In addition, she actively participates in numerous Phase I, Phase II and Phase III clinical trials in patients with chronic lymphocytic leukemia, non-Hodgkin’s lymphoma and Hodgkin’s lymphoma.